Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase

Tumor lysis syndrome (TLS) is a potentially life-threatening condition that occurs in oncologic and hematologic patients with large tumor burden, either due to cytotoxic therapy or, less commonly, spontaneously because of massive tumor cell lysis. TLS is clinically characterized by acute renal failu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alakel, Nael, Middeke, Jan Moritz, Schetelig, Johannes, Bornhäuser, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295804/
https://www.ncbi.nlm.nih.gov/pubmed/28203093
http://dx.doi.org/10.2147/OTT.S103864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295804/
https://www.ncbi.nlm.nih.gov/pubmed/28203093
http://dx.doi.org/10.2147/OTT.S103864

Ejemplares similares